Delivery Order SPE2DB22D6029-SPE2DB24FU0CT
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGE/ML pharmaceutical products. The $1,552.08 award has a performance period through February 28, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA that...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,629.58 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML. The contract has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which was not set aside for any specific business type. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has a potential value of $6,518.32 and a completion date of January 26, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a potential value of $24,443.70 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order contract is issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGEML pharmaceutical products. The $15,520.80 contract has a completion date of March 1, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and has received numerous prior federal contract awards from DLA to supply pharmaceuticals and medical supplies in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $21,184.54 contract is for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not designated as a set-aside contract....
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. The $3,080.04 firm fixed-price contract has an ultimate completion date of August 26, 2024 and was not set aside for any specific business category. AmerisourceBergen, through its Corporate Office division, will deliver the medical supplies to support various federal healthcare programs and facilities,...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $14,666.22 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGEML. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and runs through December 31, 2025. The IDC serves as Amerisourcebergen's primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $31,405.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 50 MG/0.5 ML SYRINGE 0.5ML. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BEYFORTUS 100 MG/ML syringes. The contract has a potential value of $3,259.16 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization based in Conshohocken, Pennsylvania, and is the parent company of Cencora, Inc....
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0CTDelivery Order
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BEYFORTUS 100 MG/ML SYRINGEML pharmaceutical products. The contract, valued at $4,656.24, has a period of performance through February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this specific award. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 2/28/24 |